Hi everyone,
We are pleased to report that, following their recent appraisal, NICE has recommended belimumab (Benlysta) as an option to be added to standard therapy for some lupus patients.
A change to the eligibility criteria should result in more people with severe and refractory SLE being able to access this treatment through the NHS.
You can read more about this at lupusuk.org.uk/belimumab-ap...